Page 17 - Planegg News Today

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...

The biotech company Morphosys has presented detailed results from its study with its promising drug pelabresib in the treatment of myelofibrosis. In the Phase 3 trial for the treatment of this type of...

EQS-News: MorphoSys AG / Key word(s): Conference MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in...

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Correction of a release from 07.12.2023 according to Article 40, Section 1 of the WpHG [the German Securities Trading...

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...

Speciality chemicals company Clariant is going to shut its Sunliquid bioethanol production plant in Podari, Romania. This decision comes after strategic evaluations revealed that the plant, which started producing bioethanol in 2022, did not meet operational targets and continued to incur losses.

Clariant cut its full year earnings guidance on Wednesday after it said it would close its bioethanol plant in Romania and downsize its operations in Germany. The Swiss company said 120...